Nutex Health Inc. Segments Disclosure
| Year ended December 31, | |||||||||||||||||
| 2025 | 2024 | 2023 | |||||||||||||||
| Revenue from external customers: | |||||||||||||||||
| Hospital division | $ | 844,162 | $ | 449,064 | $ | 218,070 | |||||||||||
| Population health management division | 31,095 | 30,885 | 29,576 | ||||||||||||||
| Total revenue | $ | 875,257 | $ | 479,949 | $ | 247,646 | |||||||||||
| Revenue from inter-segment activities (expense): | |||||||||||||||||
| Real estate division | $ | 2,490 | $ | 2,420 | $ | (800) | |||||||||||
| Segment expenses: | |||||||||||||||||
| Hospital division | |||||||||||||||||
| Payroll | $ | 156,770 | $ | 114,158 | $ | 103,781 | |||||||||||
| Contract services | 162,723 | 77,789 | 19,455 | ||||||||||||||
| Medical supplies | 17,241 | 15,285 | 14,151 | ||||||||||||||
| Other hospital division expenses | 44,108 | 29,512 | 28,407 | ||||||||||||||
| Hospital division expenses | 380,842 | 236,744 | 165,794 | ||||||||||||||
| Population health management division expenses | 28,875 | 27,971 | 29,487 | ||||||||||||||
| Total segment expenses | $ | 409,717 | $ | 264,715 | $ | 195,281 | |||||||||||
| Depreciation and amortization: | |||||||||||||||||
| Hospital division | $ | 18,734 | $ | 16,781 | $ | 15,941 | |||||||||||
| Population health management division | 1,360 | 1,533 | 1,648 | ||||||||||||||
| Real estate division | 436 | 658 | 3 | ||||||||||||||
| Total depreciation and amortization | $ | 20,530 | $ | 18,972 | $ | 17,592 | |||||||||||
| Segment operating income (loss): | |||||||||||||||||
| Hospital division | $ | 444,027 | $ | 195,539 | $ | 36,336 | |||||||||||
| Population health management division | 690 | 1,381 | (1,559) | ||||||||||||||
| Real estate division | (436) | (658) | (3) | ||||||||||||||
| Total segment operating income | $ | 444,281 | $ | 196,262 | $ | 34,774 | |||||||||||
| Consolidated operating income (loss) | |||||||||||||||||
| Total segment operating income | $ | 444,281 | $ | 196,262 | $ | 34,774 | |||||||||||
| Corporate and other costs | (168,656) | (65,564) | (66,548) | ||||||||||||||
| Consolidated operating income (loss) | $ | 275,625 | $ | 130,698 | $ | (31,774) | |||||||||||
| Segment other income (loss): | |||||||||||||||||
| Hospital division | |||||||||||||||||
| Interest expense, net | $ | 23,077 | $ | 18,284 | $ | 14,042 | |||||||||||
| Other expense (income) | 8,700 | (333) | 142 | ||||||||||||||
| Hospital division income before income taxes | $ | 412,250 | $ | 177,588 | $ | 22,152 | |||||||||||
| Population health management division income (loss) before income taxes | 708 | 1,613 | (1,656) | ||||||||||||||
| Real estate division loss before income taxes | (436) | (658) | (3) | ||||||||||||||
| Non-segment loss before income taxes | (167,741) | (68,717) | (68,984) | ||||||||||||||
| Income (loss) before income taxes | $ | 244,781 | $ | 109,826 | $ | (48,491) | |||||||||||
| Capital expenditures: | |||||||||||||||||
| Hospital division | $ | 2,647 | $ | 2,304 | $ | 9,497 | |||||||||||
| Total capital expenditures | $ | 2,647 | $ | 2,304 | $ | 9,497 | |||||||||||
| December 31, | |||||||||||
| 2025 | 2024 | ||||||||||
| Assets: | |||||||||||
| Hospital division | $ | 851,344 | $ | 607,590 | |||||||
| Population health management division | 29,505 | 28,338 | |||||||||
| Real estate division | 37,676 | 19,392 | |||||||||
| Total Assets | $ | 918,525 | $ | 655,320 | |||||||
Want the next Nutex Health Inc. segments disclosure the moment it drops?
Set a Sentinel and we'll alert you the moment Nutex Health Inc.'s next filing hits EDGAR. No credit card, your email never gets sold.
Historical Timeline
| Fiscal Year | Filed | |
|---|---|---|
| 2025 | Mar 5, 2026 | Showing above |
| 2024 | Mar 31, 2025 | |
| 2023 | Mar 29, 2024 | |
| 2022 | Mar 3, 2023 | |
About Segments Disclosures
Segment disclosures break a company into its reportable operating units, revealing revenue, profit, and asset allocation that consolidated financial statements obscure. Under ASC 280, segments must match how the chief operating decision maker views the business, providing a window into internal management structure and resource allocation priorities.
Key signals: compare segment margins to identify which units drive profitability and which destroy value. Watch for changes in the number of reportable segments — segment aggregation or disaggregation often coincides with strategic shifts or attempts to obscure declining performance. Intersegment elimination patterns reveal internal pricing practices. The reconciliation between segment totals and consolidated figures exposes corporate overhead allocation and unallocated items. Geographic revenue concentration highlights regulatory and currency exposure. Compare segment-level capital expenditure against segment revenue to assess where management is investing for future growth versus harvesting existing assets.